Q Therapeutics is focused on developing novel products to treat debilitating and often fatal diseases of the central nervous system. Our initial product, Q-Cells®, is being developed to treat diseases such as: Multiple Sclerosis, which affects half a million Americans; ALS, commonly called Lou Gehrig’s Disease, which typically kills patients a few years after their initial diagnosis and causes one out of every 800 deaths in the US; Spinal Cord Injury, which paralyzes 10,000 new Americans each year. Over 1,000,000 people in the US live with SCI.